| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 18 May 2026 | 13 May 2026 |
| Financial Results Invicta Diagnostic Limited has submitted to the Exchange, the standalone and consolidated financial results for the period ended March 31, 2026. (As Per NSE Announcement Dated On : 18.05.2026) | ||
| Board Meeting | 13 May 2026 | 13 May 2026 |
| Invicta Diagnostic Limited has informed the Exchange regarding Appointment of Shrenik Nagaonkar and Associates as Secretarial Auditor of the company w.e.f. May 13, 2026. | ||
| Board Meeting | 11 Apr 2026 | 11 Apr 2026 |
| Invicta Diagnostic Limited has informed the Exchange about update in Acquisition of Vinchurkar Diagnostics Private Limited | ||
| Board Meeting | 25 Mar 2026 | 21 Mar 2026 |
| To consider other business matters I. Appointment of Mr. Rohit Prakash Srivastava (DIN: 01432112) as Additional Director (Whole Time Director- Finance) of the Company. II. Approval of Material Related Party Transactions in the ordinary course of business and on arm s length basis, pursuant Section 188 of the Companies Act, 2013, subject to approval of shareholders in ensuing Extra Ordinary General Meeting III. Approval of Related Party Transactions , in the ordinary course of business and on arm s length basis, pursuant Section 188 of the Companies Act, 2013, subject to approval of shareholders in ensuing Extra Ordinary General Meeting IV. Approval for Change, Deviation and Variation in the Objects of Utilisation of the Initial Public Offering ( IPO ) Proceeds and extension of time limit for utilisation of the IPO Proceeds subject to approval of shareholders in ensuing Extra Ordinary General Meeting V. To fix Day, Date, Time of ensuing Extra Ordinary General Meeting Invicta Diagnostic Limited has informed the Exchange regarding Outcome of Board Meeting held on March 25, 2026 (As Per NSE Announcement Dated On : 25.03.2026) | ||
| Board Meeting | 5 Jan 2026 | 5 Jan 2026 |
| Invicta Diagnostic Limited has informed the Exchange about the Board of Directors, at its meeting held today i.e. January 05, 2026, has approved the 1. Incorporation of Shegaon Diagnostic LLP.2. Incorporation of Invicta Diagnostic Healthplus LLP.3. Incorporation of Invicta Diagnostic Lifecare LLP.4. Acquisition of majority stake in Vinchurkar Diagnostic Private Limited. | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
